Global Retirement Partners LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Global Retirement Partners LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,436 shares of the healthcare conglomerate’s stock after purchasing an additional 386 shares during the quarter. Global Retirement Partners LLC’s holdings in UnitedHealth Group were worth $9,832,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. AMF Tjanstepension AB raised its holdings in UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC raised its stake in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the period. Wealth Group Ltd. grew its holdings in UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares during the last quarter. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group in the third quarter worth about $341,000. Finally, Trilogy Capital Inc. grew its stake in shares of UnitedHealth Group by 6.3% during the third quarter. Trilogy Capital Inc. now owns 857 shares of the healthcare conglomerate’s stock valued at $501,000 after buying an additional 51 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $501.52 on Wednesday. The firm has a market capitalization of $461.54 billion, a price-to-earnings ratio of 32.36, a PEG ratio of 1.43 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50-day simple moving average is $521.08 and its 200-day simple moving average is $562.03. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on UNH. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.